Type 2 inflammation in asthma and other airway diseases

医学 免疫学 美波利祖马布 奥马佐单抗 先天性淋巴细胞 苯拉唑马布 哮喘 白细胞介素13 哮喘的病理生理学 炎症 免疫球蛋白E 免疫系统 过敏性炎症 嗜酸性粒细胞 先天免疫系统 白细胞介素4 抗体
作者
Jorge Máspero,Yochai Adir,Mona Al‐Ahmad,C.A. Celis-Preciado,Federico D. Colodenco,Pedro Giavina‐Bianchi,Hani Lababidi,Olivier Ledanois,Bassam Mahoub,Diahn‐Warng Perng,Juan Carlos Vázquez-García,Arzu Yorgancıoğlu
出处
期刊:ERJ Open Research [European Respiratory Society]
卷期号:8 (3): 00576-2021 被引量:113
标识
DOI:10.1183/23120541.00576-2021
摘要

Chronic inflammatory airway diseases, including asthma, chronic rhinosinusitis, eosinophilic COPD and allergic rhinitis are a global health concern. Despite the coexistence of these diseases and their common pathophysiology, they are often managed independently, resulting in poor asthma control, continued symptoms and poor quality of life. Understanding disease pathophysiology is important for best treatment practice, reduced disease burden and improved patient outcomes. The pathophysiology of type 2 inflammation is driven by both the innate immune system triggered by pollutants, viral or fungal infections involving type 2 innate lymphoid cells (ILC2) and the adaptive immune system, triggered by contact with an allergen involving type 2 T-helper (Th2) cells. Both ILC2 and Th2 cells produce the type-2 cytokines (interleukin (IL)-4, IL-5 and IL-13), each with several roles in the inflammation cascade. IL-4 and IL-13 cause B-cell class switching and IgE production, release of pro-inflammatory mediators, barrier disruption and tissue remodelling. In addition, IL-13 causes goblet-cell hyperplasia and mucus production. All three interleukins are involved in trafficking eosinophils to tissues, producing clinical symptoms characteristic of chronic inflammatory airway diseases. Asthma is a heterogenous disease; therefore, identification of biomarkers and early targeted treatment is critical for patients inadequately managed by inhaled corticosteroids and long-acting β-agonists alone. The Global Initiative for Asthma guidelines recommend add-on biological (anti IgE, IL-5/5R, IL-4R) treatments for those not responding to standard of care. Targeted therapies, including omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab and tezepelumab, were developed on current understanding of the pathophysiology of type 2 inflammation. These therapies offer hope for improved management of type 2 inflammatory airway diseases.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
1秒前
jessica发布了新的文献求助10
2秒前
乐乐应助落寞之云采纳,获得10
2秒前
英勇的人生完成签到,获得积分10
3秒前
bkagyin应助风清扬采纳,获得10
3秒前
4秒前
5秒前
拼尽全力发布了新的文献求助10
6秒前
17712570999发布了新的文献求助10
6秒前
酷酷的皮皮虾完成签到,获得积分10
6秒前
乐情发布了新的文献求助10
6秒前
7秒前
7秒前
33应助苗条的辣辣采纳,获得10
7秒前
科研通AI2S应助苗条的辣辣采纳,获得10
7秒前
闻屿完成签到,获得积分10
8秒前
juntang完成签到,获得积分10
8秒前
zzzy发布了新的文献求助10
8秒前
能干冰露发布了新的文献求助10
8秒前
睿籽完成签到,获得积分10
9秒前
wanci应助酷酷的皮皮虾采纳,获得10
9秒前
史克珍香完成签到 ,获得积分10
10秒前
11秒前
CodeCraft应助潘嫄采纳,获得10
11秒前
在水一方应助上善若水采纳,获得10
12秒前
12秒前
pluto应助飞哥采纳,获得10
12秒前
hepotosis发布了新的文献求助10
12秒前
NexusExplorer应助小璐璐呀采纳,获得10
14秒前
ZZY发布了新的文献求助10
16秒前
17秒前
17秒前
能干冰露完成签到,获得积分10
17秒前
18秒前
zz完成签到,获得积分10
18秒前
围城发布了新的文献求助10
19秒前
Jerry完成签到,获得积分10
19秒前
DE关闭了DE文献求助
19秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975250
求助须知:如何正确求助?哪些是违规求助? 3519625
关于积分的说明 11199055
捐赠科研通 3255962
什么是DOI,文献DOI怎么找? 1798001
邀请新用户注册赠送积分活动 877358
科研通“疑难数据库(出版商)”最低求助积分说明 806298